Bookbuilding IPO | ₹1,842 Cr | Listed at BSE, NSE | Mon, May 6, 2024 - Wed, May 8, 2024
Indegene IPO is a book build issue of ₹1,841.76 crores. The issue is a combination of fresh issue of 1.68 crore shares aggregating to ₹760.52 crores and offer for sale of 2.39 crore shares aggregating to ₹1,081.24 crores.
Indegene IPO bidding started from May 6, 2024 and ended on May 8, 2024. The allotment for Indegene IPO was finalized on May 9, 2024. The shares got listed on BSE, NSE on May 13, 2024.
Indegene IPO price band is set at ₹452 per share. The lot size for an application is 33. The minimum amount of investment required by an retail is ₹14,916 (33 shares) (based on upper price). The lot size investment for sNII is 14 lots (462 shares), amounting to ₹2,08,824, and for bNII, it is 68 lots (2,244 shares), amounting to ₹10,14,288.
The issue includes a reservation of up to 2,96,208 shares for employees offered at a discount of ₹30.00 to the issue price.
Kotak Mahindra Capital Co.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Indegene IPO RHP for detailed Information.
IPO Open
Mon, May 6, 2024
IPO Close
Wed, May 8, 2024
Issue Price
₹452 per share
Market Cap (Pre-IPO)
₹10,814.07 Cr
| IPO Date | 6 to 8 May, 2024 |
| Listed on | Mon, May 13, 2024 |
| Face Value | ₹2 per share |
| Price Band | ₹430 to ₹452 |
| Issue Price | ₹452 per share |
| Lot Size | 33 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Employee Discount | ₹30.00 |
| Total Issue Size | 4,07,66,550 shares (agg. up to ₹1,842 Cr) |
| Fresh Issue | 1,68,33,818 shares (agg. up to ₹761 Cr) |
| Offer for Sale | 2,39,32,732 shares of ₹2 (agg. up to ₹1,081 Cr) |
| Share Holding Pre Issue | 22,24,35,091 shares |
| Share Holding Post Issue | 23,92,49,250 shares |
| BSE Script Code / NSE Symbol | 544172 / INDGN |
| ISIN | INE065X01017 |
Indegene IPO offers total 4,07,66,550 shares. Out of which 2,02,35,170 (49.64%) allocated to QIB, 80,94,068 (19.85%) allocated to QIB (Ex- Anchor), 60,70,552 (14.89%) allocated to NII 1,41,64,620 (34.75%) allocated to RII and 1,21,41,102 (29.78%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 2,02,35,170 (49.64%) | NA |
| − Anchor Investor Shares Offered | 1,21,41,102 (29.78%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 80,94,068 (19.85%) | NA |
| NII (HNI) Shares Offered | 60,70,552 (14.89%) | NA |
| − bNII > ₹10L | 40,47,034 (9.93%) | 8,759 |
| − sNII < ₹10L | 20,23,518 (4.96%) | 4,379 |
| Retail Shares Offered | 1,41,64,620 (34.75%) | 4,29,230 |
| Employee Shares Offered | 2,96,208 (0.73%) | NA |
| Total Shares Offered | 4,07,66,550 (100.00%) |
Investors can bid for a minimum of 33 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,916 |
| Retail (Max) | 13 | 429 | ₹1,93,908 |
| S-HNI (Min) | 14 | 462 | ₹2,08,824 |
| S-HNI (Max) | 67 | 2,211 | ₹9,99,372 |
| B-HNI (Min) | 68 | 2,244 | ₹10,14,288 |
Indegene IPO raises ₹548.78 crore from anchor investors. Indegene IPO Anchor bid date is May 3, 2024.
📝 Anchor Investors Letter (PDF)
| Bid Date | Fri, May 3, 2024 |
| Shares Offered | 1,21,41,102 |
| Anchor Portion (₹ Cr.) | 548.78 |
| Anchor lock-in period end date for 50% shares (30 Days) | Sat, Jun 8, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | Wed, Aug 7, 2024 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
The company's services can be divided into following categories
The subsidiary of the company, DT Associates Limited, provides consulting services under the "DT Consulting" brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.
The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.
As of December 31, 2023, the company had 65 clients actively engaged with its services.
As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 2,518.15 | 2,203.87 | 1,353.47 | 596.04 |
| Total Income | 1,969.75 | 2,364.10 | 1,690.50 | 996.92 |
| Profit After Tax | 241.90 | 266.10 | 162.82 | 149.41 |
| NET Worth | 1,327.00 | 1,063.72 | 763.90 | 324.51 |
| Reserves and Surplus | 1,282.65 | 1,019.43 | 763.55 | 324.19 |
| Total Borrowing | 399.33 | 394.34 | 18.24 | 24.76 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/prepaymentof indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc | 391.34 |
| 2 | Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc. | 102.92 |
| 3 | General Corporate Purposes and Inorganic Growth | 230.12 |
| KPI | Dec 31, 2023 |
|---|---|
| Debt/Equity | 0.30 |
| RoNW | 18.23% |
| PAT Margin | 12.62% |
| Price to Book Value | 7.55 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 11.96 | 13.48 |
| P/E (x) | 37.78 | 33.53 |
| Promoter Holding | 30.71% | |
| Market Cap | ₹10,814.07 Cr. |
The Indegene IPO is subscribed 70.3 times on May 8, 2024 6:19:05 PM (Day 3). The public issue subscribed 7.86 times in the retail category, 192.72 times in the QIB category, and 55.91 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 192.72 | 80,94,069 | 1,55,98,65,945 |
| NII | 55.91 | 60,70,552 | 33,93,99,126 |
| bNII (bids above ₹10L) | 62.23 | 40,47,034 | 25,18,64,613 |
| sNII (bids below ₹10L) | 43.26 | 20,23,518 | 8,75,34,513 |
| Retail | 7.86 | 1,41,64,620 | 11,12,71,347 |
| Employee | 6.62 | 2,96,209 | 19,62,114 |
| Total | 70.3 | 2,86,25,450 | 2,01,24,98,532 |
Total Application : 27,93,616
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to the BRLMs including underwriting commission, brokerage and selling commission, as applicable | 46.25 |
| 2 | Commission/processing fee for SCSBs, Sponsor Bank(s) and Banker(s) to the Offer and brokerage, underwriting and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 2.36 |
| 3 | Fees payable to the Registrar to the Offer | 0.13 |
| 4 | Fees payable to the auditors, consultants and industry experts | 9.13 |
| 5 | Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses | 7.78 |
| 6 | Printing stationery | 1.84 |
| 7 | Advertising and marketing expenses | 3.92 |
| 8 | Fee payable to legal counsels | 10.27 |
| 9 | Miscellaneous | 4.67 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹452.00 | ₹452.00 |
| Open | ₹659.70 | ₹655.00 |
| Low | ₹527.80 | ₹527.10 |
| High | ₹659.70 | ₹660.00 |
| Last Trade | ₹570.65 | ₹570.90 |
Indegene IPO is a main-board IPO of 4,07,66,550 equity shares of the face value of ₹2 aggregating up to ₹1,842 Crores. The issue is priced at ₹452 per share. The minimum order quantity is 33.
The IPO opens on Mon, May 6, 2024, and closes on Wed, May 8, 2024.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Indegene IPO using UPI as a payment gateway. Zerodha customers can apply in Indegene IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Indegene IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Indegene IPO opens on Mon, May 6, 2024 and closes on Wed, May 8, 2024.
Indegene IPO lot size is 33, and the minimum amount required for application is ₹14,916.
You can apply in Indegene IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Indegene IPO will be done on Thursday, May 9, 2024, and the allotted shares will be credited to your demat account by Fri, May 10, 2024. Check the Indegene IPO allotment status.
The Indegene IPO listing date is on Mon, May 13, 2024.
